VisiLoc
SenoRx extends the EnCor breast biopsy product line into the MRI arena by offering grid and pillar/post compatibility in the same EnCor MRI product.
The most significant feature of the MRI product line is the MRI visible obturator, VisiLoc. The VisiLoc obturator provides high visibility through a safe, positive-contrast mechanism that reinforces physician confidence in targeting with each procedure.
Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...
February 02, 2026 
Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...
January 29, 2026 
Jan. 027, 2026 — QT Imaging and Olea Medical have announced plans to collaborate. This collaboration enhances QT Imaging ...
January 27, 2026 
Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...
January 16, 2026 
Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...
December 02, 2025 
Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...
November 04, 2025 
Aug. 19, 2025 — According to the latest study from BCC Research, the "Global Mammography Equipment Markets" is projected ...
August 20, 2025 
April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...
April 24, 2025 
GRACE Breast Imaging & Medical Spa of Iowa, with locations in Urbandale and Clive, recently became the first healthcare ...
January 24, 2025 
Nov. 25, 2024 — CancerIQ has launched a new patient acquisition solution for imaging and oncology, CancerIQ Reach.The ...
December 03, 2024 